Quest Diagnostics (DGX) Accumulated Depreciation & Amortization (2016 - 2024)
Historic Accumulated Depreciation & Amortization for Quest Diagnostics (DGX) over the last 16 years, with Q4 2024 value amounting to $493.0 million.
- Quest Diagnostics' Accumulated Depreciation & Amortization rose 1230.07% to $493.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $493.0 million, marking a year-over-year increase of 1230.07%. This contributed to the annual value of $493.0 million for FY2024, which is 1230.07% up from last year.
- Quest Diagnostics' Accumulated Depreciation & Amortization amounted to $493.0 million in Q4 2024, which was up 1230.07% from $439.0 million recorded in Q4 2023.
- In the past 5 years, Quest Diagnostics' Accumulated Depreciation & Amortization registered a high of $493.0 million during Q4 2024, and its lowest value of $361.0 million during Q4 2020.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $437.0 million (2022), whereas its average is $427.6 million.
- In the last 5 years, Quest Diagnostics' Accumulated Depreciation & Amortization soared by 1301.94% in 2021 and then surged by 45.77% in 2023.
- Quarter analysis of 5 years shows Quest Diagnostics' Accumulated Depreciation & Amortization stood at $361.0 million in 2020, then increased by 13.02% to $408.0 million in 2021, then rose by 7.11% to $437.0 million in 2022, then rose by 0.46% to $439.0 million in 2023, then increased by 12.3% to $493.0 million in 2024.
- Its Accumulated Depreciation & Amortization was $493.0 million in Q4 2024, compared to $439.0 million in Q4 2023 and $437.0 million in Q4 2022.